The Effect of a New Glucose–Methotrexate Conjugate on Acute Lymphoblastic Leukemia and Non-Hodgkin’s Lymphoma Cell Lines

Patients with hematologic malignancies require intensive therapies, including high-dose chemotherapy. Antimetabolite–methotrexate (MTX) has been used for many years in the treatment of leukemia and in lymphoma patients. However, the lack of MTX specificity causes a significant risk of morbidity, mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Woźniak, Marta, Makuch, Sebastian, Pastuch-Gawołek, Gabriela, Wiśniewski, Jerzy, Szeja, Wiesław, Nowak, Martyna, Krawczyk, Monika, Agrawal, Siddarth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123764/
https://www.ncbi.nlm.nih.gov/pubmed/33925555
http://dx.doi.org/10.3390/molecules26092547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123764/
https://www.ncbi.nlm.nih.gov/pubmed/33925555
http://dx.doi.org/10.3390/molecules26092547

Ejemplares similares